{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1713572", "DateCompleted": {"Year": "1991", "Month": "09", "Day": "05"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "16"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0020-5915", "JournalIssue": {"Volume": "93", "Issue": "4", "PubDate": {"Year": "1990"}}, "Title": "International archives of allergy and applied immunology", "ISOAbbreviation": "Int Arch Allergy Appl Immunol"}, "ArticleTitle": "Selective inhibition by magnosalin and magnoshinin, compounds from 'shin-i' (Flos magnoliae), of adjuvant-induced angiogenesis and granuloma formation in the mouse pouch.", "Pagination": {"StartPage": "365", "EndPage": "370", "MedlinePgn": "365-70"}, "Abstract": {"AbstractText": ["Inhibitory effects of magnosalin and magnoshinin, compounds from the crude drug 'Shin-i' (Flos magnoliae), on angiogenesis and pouch granuloma formation induced by an adjuvant containing croton oil were investigated. Magnosalin inhibited angiogenesis 2.4-fold (intra-pouch) and 9.7-fold (intraperitoneal) more strongly than granuloma formation. The inhibition of angiogenesis by magnosalin was 5-fold (intra-pouch) and 21-fold (intraperitoneal) weaker than that by hydrocortisone. In contrast, intraperitoneal magnoshinin inhibited granuloma formation 2.5-fold more strongly than angiogenesis. The regression coefficients of anti-angiogenesis vs. the inhibition of granuloma formation were 1.79 for magnosalin, 1.11 for hydrocortisone, and 0.61 for magnoshinin. These results show that the anti-chronic inflammatory effect of 'Shin-i' was caused by selective inhibition of angiogenesis by magnosalin and of granuloma formation by magnoshinin."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Japan."}], "LastName": "Kimura", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kobayashi", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Luo", "ForeName": "B", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kimura", "ForeName": "I", "Initials": "I"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int Arch Allergy Appl Immunol", "NlmUniqueID": "0404561", "ISSNLinking": "0020-5915"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adjuvants, Immunologic"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclobutanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Lignans"}, {"RegistryNumber": "0", "NameOfSubstance": "Naphthols"}, {"RegistryNumber": "73036-51-8", "NameOfSubstance": "magnosalin"}, {"RegistryNumber": "86702-02-5", "NameOfSubstance": "magnoshinin"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage"], "DescriptorName": "Adjuvants, Immunologic"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cyclobutanes"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Granuloma"}, {"QualifierName": [], "DescriptorName": "Injections, Intraperitoneal"}, {"QualifierName": [], "DescriptorName": "Lignans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Naphthols"}, {"QualifierName": [], "DescriptorName": "Neovascularization, Pathologic"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Peritoneal Diseases"}, {"QualifierName": ["blood supply"], "DescriptorName": "Peritoneum"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["blood supply"], "DescriptorName": "Skin"}, {"QualifierName": ["chemically induced", "prevention & control"], "DescriptorName": "Skin Diseases"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1990", "Month": "1", "Day": "1"}, {"Year": "1990", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1990", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1713572", "10.1159/000235267"]}}]}